Your session is about to expire
← Back to Search
Prescribing Practices Feedback for Older Patients (EQUIPPED Trial)
N/A
Waitlist Available
Led By George Lee Jackson, PhD MHA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months post implementation of equipped
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at whether presenting information to doctors about their prescribing practices will influence whether they prescribe fewer potentially harmful medications to older adults. They will also look at what factors make it more likely for a hospital to adopt this program.
Who is the study for?
This trial is for prescribers and members of the EQUIPPED implementation team at VA Medical Centers that are starting to use EQUIPPED. It's focused on improving how doctors prescribe medication to older veterans in the emergency department (ED) to avoid inappropriate medications.
What is being tested?
The study tests two ways of giving feedback to ED providers using EQUIPPED: 'Passive Feedback' where they get general updates, and 'Active Feedback' with more direct guidance. The goal is to see which method better reduces unsuitable prescriptions for elderly patients.
What are the potential side effects?
Since this trial focuses on prescribing practices rather than a specific medication, it doesn't have traditional side effects. However, changes in prescription habits may affect patient outcomes, which will be closely monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months post implementation of equipped
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months post implementation of equipped
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage of PIMs Prescribed
Secondary study objectives
Impact of EQUIPPED on Behavior Change and Factors Impacting Implementation
Micro-Costing the Active and Passive Feedback Versions of the EQUIPPED Intervention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Active FeedbackActive Control1 Intervention
EQUIPPED with active provider feedback, implementing one-to-one (1:1) in-person academic detailing from a professional colleague that includes in-person audit, feedback, and peer benchmarking and provide on-site expertise.
Group II: Passive FeedbackActive Control1 Intervention
EQUIPPED with passive provider feedback, implementing monthly provider feedback via an electronic dashboard with audit, feedback and peer benchmarking.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,792 Total Patients Enrolled
25 Trials studying Aging
3,027 Patients Enrolled for Aging
Birmingham, Alabama VA Medical CenterFED
3 Previous Clinical Trials
452 Total Patients Enrolled
1 Trials studying Aging
228 Patients Enrolled for Aging
Durham VA Health Care SystemFED
7 Previous Clinical Trials
64,823 Total Patients Enrolled
VA Salt Lake City Health Care SystemFED
24 Previous Clinical Trials
261,989 Total Patients Enrolled
George Lee Jackson, PhD MHAPrincipal InvestigatorDurham VA Medical Center, Durham, NC
Elizabeth Camille Vaughan, MD MSPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
2 Previous Clinical Trials
363 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- are not to prescribe more than a seven day supply of opioids for a new patient for any reasonwill work with study coordinators to ensure that all EQUIPPED study procedures are followed
Research Study Groups:
This trial has the following groups:- Group 1: Active Feedback
- Group 2: Passive Feedback
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.